Partner Sessions

Outline how innovative, automated solutions are essential for scaling up manufacturing and preparing cell therapies for approval in earlier treatment lines.

Of Interest To:
Developers, Regulators, Biomanufacturers, CDMOs, Researchers, Quality Professionals, Manufacturers, Industry, Quality Personnel, Manufacturing & Processing Centers, Lab Directors, PIs

Discuss the impact of regional regulatory differences on ancillary materials for cell and gene therapy and their effects on manufacturers and therapy developers.

Of Interest To:
Developers, Regulators, Biomanufacturers, CDMOs, Researchers, Quality Professionals, Manufacturers, Industry, Quality Personnel, Manufacturing & Processing Centers, Lab Directors, PIs

Discuss key challenges that limit patient access to CGTs and debate how healthcare decisions should frame these challenges given quality-of-life considerations that are specific to CGTs.

Of Interest To:
Developers, Regulators, Policy-Makers, CDMOs, Investors, Researchers, Quality Professionals, Manufacturers, Lab Professionals, Industry, Business Development Professionals, Regulatory Professionals, Therapy Developers

How can adopting data-driven manufacturing and advanced analytics optimize cell health data, build predictive models, and ensure quality control, to ultimately making these therapies more accessible and cost-effective?

Of Interest To:
Developers, Regulators, Policy-Makers, Biomanufacturers, CDMOs, Investors, Researchers, Data Scientists, Quality Professionals, Manufacturers, Lab Professionals, Cold Chain Professionals, Industry, Quality Personnel, Enablers, Start-Ups, Business Development Professionals, Manufacturing & Processing Centers, Lab Directors, PIs, Operations Upper-Management